investorscraft@gmail.com

Intrinsic ValueOption Care Health, Inc. (OPCH)

Previous Close$28.48
Intrinsic Value
Upside potential
Previous Close
$28.48

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Option Care Health, Inc. operates as a leading provider of home and alternate-site infusion therapy services in the U.S. healthcare sector. The company specializes in delivering cost-effective, high-quality clinical solutions for patients with acute and chronic conditions, including immune deficiencies, bleeding disorders, and neurological disorders. Its revenue model is driven by reimbursements from payers such as Medicare, Medicaid, and private insurers, supported by a scalable platform that optimizes care coordination and operational efficiency. Option Care Health distinguishes itself through its national footprint, clinical expertise, and integrated pharmacy services, positioning it as a trusted partner for healthcare providers and payers. The company benefits from long-term industry tailwinds, including the shift toward home-based care and the growing prevalence of chronic diseases. Its competitive moat lies in its regulatory compliance, proprietary protocols, and ability to manage complex therapies, which create barriers to entry for smaller players.

Revenue Profitability And Efficiency

Option Care Health reported revenue of $4.998 billion for FY 2024, reflecting steady demand for its infusion services. Net income stood at $211.8 million, with diluted EPS of $1.23, indicating disciplined cost management. Operating cash flow of $323.4 million underscores the company’s ability to convert earnings into liquidity, though capital expenditures were negligible, suggesting limited near-term growth investments.

Earnings Power And Capital Efficiency

The company demonstrates solid earnings power, with a net margin of approximately 4.2%. Its capital efficiency is supported by a scalable asset-light model, as evidenced by robust operating cash flow relative to net income. The absence of capital expenditures in the period suggests a focus on optimizing existing infrastructure rather than expansion.

Balance Sheet And Financial Health

Option Care Health maintains a balanced financial position, with $412.6 million in cash and equivalents against $1.218 billion in total debt. The liquidity position appears adequate, though leverage metrics warrant monitoring given the debt load. The lack of dividends aligns with a reinvestment strategy aimed at sustaining organic growth.

Growth Trends And Dividend Policy

Revenue growth is likely tied to demographic trends and payer preferences for home-based care. The company has not instituted a dividend, prioritizing reinvestment in clinical capabilities and potential M&A. Future growth may hinge on expanding service lines and geographic penetration, supported by industry tailwinds.

Valuation And Market Expectations

With a diluted EPS of $1.23 and a scalable model, the market likely prices OPCH on growth potential rather than current earnings. Valuation multiples should reflect the company’s position in a fragmented industry with consolidation opportunities, though competitive pressures and reimbursement risks remain key considerations.

Strategic Advantages And Outlook

Option Care Health’s strategic advantages include its national scale, clinical expertise, and payer relationships. The outlook is positive, supported by healthcare cost containment trends favoring home infusion. Execution risks include regulatory changes and integration challenges from acquisitions, but the company is well-positioned to capitalize on industry shifts.

Sources

10-K filing, CIK 0001014739

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount